本页面由Tiger Trade Technology Pte. Ltd.提供服务

NLS Pharmaceutics Ltd.

0.7620
0.0000
成交量:- -
成交额:- -
市值:396.74万
市盈率:- -
高:0.7620
开:0.7620
低:0.7620
收:0.7620
52周最高:18.60
52周最低:0.7620
股本:520.66万
流通股本:341.80万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(LYR):-2.6288
净资产收益率:-862.92%
总资产收益率:-75.98%
市净率:1.41
市盈率(LYR):-0.29

数据加载中...

2024/12/11

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/11/25

SEC问询函

Form CORRESP - Correspondence
2024/11/21

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/18

SEC问询函

Form CORRESP - Correspondence
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/06

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/11/04

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/04

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/04

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/10/15

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/08/27

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/06/25

SEC问询函

Form CORRESP - Correspondence
2024/05/30

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/05/16

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/27

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/05/05

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/24

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals